4.7 Review

Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique

期刊

ANNALS OF SURGICAL ONCOLOGY
卷 17, 期 5, 页码 1219-1225

出版社

SPRINGER
DOI: 10.1245/s10434-010-0976-5

关键词

-

资金

  1. Onyx Pharmaceuticals/Bayer Healthcare Pharmaceuticals
  2. Sanofi-aventis
  3. NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Hepatocellular carcinoma remains a leading cause of cancer death worldwide. There are an increasing number of patients that do not meet traditional criteria for surgical resection as a result of historically poor outcomes. We define these oncologically high-risk patients as those with either one of these risk factors or a combination of them: large (> 5 cm) primary tumors, multinodular disease, and/or major vascular invasion. With appropriate selection and preparation, long-term survival is possible in this subset of patients after resection. This review focuses on the surgical treatment of these high-risk patients, focusing on our own institution's approach and methods as well as reviewing the literature pertinent to the support of our current practice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据